Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:MNTA
Date7/2004
Raised
Post IPO Valuation

General Information

Websitemomentapharma.com
Twitter@momentapharma
CategoryBioTech
Phone617-491-9700
Emailinfo@momentapharm...
Employees
Founded2001

Offices

Cambridge, USA
675 West Kendall Street
Cambridge, MA, 02142
USA

People

CFO
CSO
President & CEO
Vice President, Business and Corporate Development
Board of Directors
Board of Directors
Advisory Board

Tags

Momenta Pharmaceuticals

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans. This results in a diversified product pipeline of complex generic, follow-on biologic and novel drugs. The Company’s two most advanced complex generic product candidates target marketed products, which were originally approved by the United States Food and Drug Administration as New Drug Applications. M-Enoxaparin is designed to be a generic version of Lovenox (enoxaparin sodium injection), a low-molecular weight heparin used to prevent and treat deep vein thrombosis. Its second major generic product candidate is M356, a generic version of Copaxone (glatiramer acetate injection), a drug that is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

    Momenta prices $57M stock offering (masshightech.com) [edit]
    Momenta hires Biogen’s Kwon for business development (masshightech.com) [edit]
    Momenta acquires Virdante assets (masshightech.com) [edit]
Edit This Page
Last Edited 3/24/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy